New Thermal Imaging Cart with Onboard Power

Supports a Healthier, Safer Return to Work Reports Ergotron

Ergotron, a global movement company that builds environments that help people thrive, announced the launch of its Thermal Imaging Cart with Onboard Power designed to quickly detect a temperature in spaces where groups of people gather.

As employers slowly start to bring their teams back to work, businesses gradually begin to reopen, and educators weigh their options for the upcoming school year, safeguarding public health is a top priority. Thermal imaging technology brings body temperature measurement wherever it’s needed to support efforts to maintain healthy communities.

Ergotron’s Thermal Imaging Cart provides total flexibility. The cart’s open architecture allows for customers to mount their thermal imaging camera of choice* facing forward or backward depending on the application or to accommodate privacy considerations. The easy-to-clean mobile cart is compact and fits in small spaces so it can travel to wherever it’s needed. Optional accessories like a sani-wipes holder make disinfection simple and the onboard LiFe battery technology provides a safe and reliable charge.

“We developed the Thermal Imaging Cart based on a need we recognized in our customers and in the marketplace,” said Megan Nightingale, general manager, industrial, education and new markets at Ergotron. “As we navigate this new world we’re in, we’ve seen a huge demand for thermal imaging solutions. Our cart fits a variety of thermal imaging cameras and we’re excited to introduce this solution to support employers, businesses and educators as they work to keep their populations healthy.”

In addition to the Thermal Imaging Cart with Onboard Power, a Thermal Imaging Cart with Hot Swap Power is also available to order. Hot swap power, with Ergotron’s innovative LifeKinnex™ Technology, allows for uninterrupted workflows. These carts can be ordered from resellers globally. For more information, visit ergotron.com or call 888-743-1999.

* Camera, monitor and other equipment sold separately. Ergotron does not manufacture, sell or endorse any thermal camera. Mobotix® is a registered trademark of Mobotix AG Corporation.

SourceErgotron

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”